Bayer quarterly profit is flat as weak animal health offsets strong Xarelto

2

Bayer which is a good futures stock paying a high dividend yield is suffering from flat profits this week.

Bayer's adjusted core earnings were flat for the quarter, as better prescription numbers for cardiovascular drug Xarelto were tempered by a weaker animal health business and a strong euro weighing on the value of overseas sales.

2 COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here